Interaction of IL-15 with the shared IL-2 receptor β and γ c subunits. The IL-15/β/γ c receptor-ligand complex is less stable than the IL-2/β/γ c receptor-ligand complex
The DOI matches its Crossref record.
Abstract
This study was designed to compare the interactions of IL-2 and IL-15 with the IL-2R β and IL-2R γ c subunits, as differences in receptor interactions between IL-2 and IL-15 might contribute to the functional differences between these two cytokines. The results suggest the existence of a human IL-15R α subunit, although physical evidence of this molecule was not obtained. Proliferation of anti-CD3 (OKT3)-stimulated human PBL was compared for responsiveness to IL-2, IL-15, and F42K, and IL-2 mutant that does not bind the IL-2R α chain. F42K was more potent than IL-15 in activating a dose-dependent response. This fact, along with Scatchard binding analyses of IL-15 on OKT3 blasts and YT cells revealing both high and intermediate affinity receptors, supports the existence of IL-15R α on these cells. Additional characterization of the IL-15R utilized covalent cross-linking to affinity label IL-2R and IL-15R on YT cells and OKT3 blasts. Consistent with previously reported functional data, IL-2R α was not co-precipitated from the [125I]IL-15 receptor-ligand complex, demonstrating that IL-15 does not interact physically with the IL-2R α subunit. While IL-2R α did co-precipitate with IL-2R β and IL-2R γ c in the presence of IL-2, IL-15R α did not co-precipitate with the IL-2R β/γ c complex. Finally, YT cells equilibrated with IL-2 and then precipitated through IL-2R β showed that IL-2R β and IL-2R γ c co-precipitate in a 1:1 ratio, while only IL-2R β was found in the immunoprecipitates of YT cells equilibrated with IL-15. This indicates that IL-15 creates a less stable bridge between the IL-2R β and IL-2R γ c chains than does IL-2 on YT cells. This result was identical for both surface-iodinated YT cells and immunoprecipitates that were probed for IL-2R β and IL-2R γ c on Western blots.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin 12: still a promising candidate for tumor immunotherapy?
Lasek, W., Zagożdżon, R., & Jakobisiak, M. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1523-1 · Cited by 495
Combined IL-15/IL-15Rα Immunotherapy Maximizes IL-15 Activity In Vivo
Stoklasek, T. A., Schluns, K. S., & Lefrançois, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6072 · Cited by 366
A primer on cytokines: sources, receptors, effects, and inducers
Curfs, J. H., Meis, J. F., & Hoogkamp-Korstanje, J. A. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.4.742 · Cited by 317
Koka, R., Burkett, P. R., Chien, M., Chai, S., Chan, F., Lodolce, J. P., Boone, D. L., & Ma, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021836 · Cited by 252
CD56+ Cells Induce Steroid Resistance in B Cells Exposed to IL-15
Xu, Q., Goleva, E., Ou, L.-S., Li, L.-B., & Leung, D. Y. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7110 · Cited by 9
Metadata
- Authors
- de Jong, J. L., Farner, N. L., Widmer, M. B., Giri, J. G., & Sondel, P. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-02
- Volume
- 156
- Issue
- 4
- Pages
- 1339-1348
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1579523632
- Cited by
- 57
- References
- 0
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interaction of IL-15 with the shared IL-2 receptor β and γ c subunits. The IL-15/β/γ c receptor-ligand complex is less stable than the IL-2/β/γ c receptor-ligand complex. https://app.cochat.ai/papers/10.4049/jimmunol.156.4.1339
- The paper
- de Jong, J. L., Farner, N. L., Widmer, M. B., Giri, J. G., & Sondel, P. M. (1996). Interaction of IL-15 with the shared IL-2 receptor β and γ c subunits. The IL-15/β/γ c receptor-ligand complex is less stable than the IL-2/β/γ c receptor-ligand complex. The Journal of Immunology. https://doi.org/10.4049/jimmunol.156.4.1339
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.